Can Mark Cuban’s new online pharmacy provide a blueprint for the future?

Almost daily, a new story emerges on the exorbitant prices families must pay to acquire vital drugs like insulin for Type-1 diabetes or Epi-Pens for those at risk of severe allergic reactions. Unsurprisingly, Americans view these high prescription costs unfavorably and have consistently demanded industry reforms. Now some companies are taking matters into their own […]

Coalition letter to Governor Hochul: S3081B is anti-taxpayer, anti-patient, and anti-free market

December 20, 2022 Dear Governor Hochul: As state and national organizations representing a wide range of U.S. taxpayers and consumers, we write today in opposition to S3081B, which seeks to impose penalties and pricing constraints for charging “an unconscionably excessive price” on any drug or medical product that the FDA has identified as being subject […]

New OHID report corrects common misconceptions about vaping

In a much-anticipated update from the Office of Health Improvement and Disparities (OHID), the British health agency released its eighth and final independent report on the health risks and effects of vaping. A team of researchers at King’s College London produced the landmark report, which was first commissioned in 2015 by Public Health England (PHE) and now by OHID. What they […]

A flurry of new tobacco rules reveals an aggressive new chapter for the FDA

The last few months have seen a whirlwind of attacks on tobacco users. From an April proposal to ban the popular menthol cigarette flavor and prohibit all cigar flavors other than traditional tobacco to a plan to eliminate nearly all nicotine in conventional cigarettes sold in the U.S., the Food and Drug Administration’s (FDA) has been busy making a flurry of announcements.  However, it was the FDA’s […]

In Banning Juul, FDA Fails to Follow the Science

Over the past year, the Food and Drug Administration has taken an increasingly aggressive and anti-scientific approach to regulating electronic cigarettes, despite empirical evidence showing they are far safer than traditional combustible products. The agency’s approach became very apparent when it ordered JUUL, a manufacturer of popular electronic cigarettes, to remove their products from the […]

Study Links PBMs to Medicine Overpayments

Much has been written about the role Pharmacy Benefit Managers (PBMs) play in driving up the cost of prescription brand named drugs. However, far less has been written about how PBMs current business practices lead U.S. consumers, employers, and the government to pay too much for what should be low-cost drugs. Now a new paper, […]

FDA’s Decision to Ban JUUL E-cigarettes Will Jeopardize American Lives

Today’s announcement by the FDA that JUUL’s vaping products will be ordered off the market is another stark reminder of the agency’s forgotten mission to protect the health of American consumers. The scientific evidence clearly shows that e-cigarettes and vaping products, while not totally safe, are 95% safer than combustible tobacco products and twice as […]